Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1711 results

This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments. This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.

by Cancer Research UK | News | 30 November 2018

30 November 2018

Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them. Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them.

by Cancer Research UK | News | 29 November 2018

29 November 2018

This entry is part 24 of 30 in the series Science Snaps
An image of an MRI scan of a brain with the glioblastoma tumour in white.

Our scientists have shown it’s possible to detect brain tumour DNA in the liquid surrounding the brain using a cheap technique. Our scientists have shown it’s possible to detect brain tumour DNA in the liquid surrounding the brain using a cheap technique.

by Gabriella Beer | Analysis | 6 November 2018

6 November 2018

Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine. Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.

by Cancer Research UK | News | 6 November 2018

6 November 2018

This entry is part 23 of 30 in the series Science Snaps

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

by In collaboration with PA Media Group | News | 24 October 2018

24 October 2018